Cargando…

Oral mineralocorticoid antagonists for recalcitrant central serous chorioretinopathy

PURPOSE: To evaluate the effect and tolerance of oral mineralocorticoid antagonists, eplerenone and/or spironolactone, in recalcitrant central serous chorioretinopathy. METHODS: Retrospective consecutive observational case series. Primary outcome measures included central macular thickness (CMT, μm)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chin, Eric K, Almeida, David RP, Roybal, C Nathaniel, Niles, Philip I, Gehrs, Karen M, Sohn, Elliott H, Boldt, H Culver, Russell, Stephen R, Folk, James C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540165/ https://www.ncbi.nlm.nih.gov/pubmed/26316684 http://dx.doi.org/10.2147/OPTH.S86778

Ejemplares similares

Incomplete Vitreomacular Traction Release Using Intravitreal Ocriplasmin
por: Chin, Eric K., et al.
Publicado: (2014)

Predictive factors of selective mineralocorticoid receptor antagonist treatment in chronic central serous chorioretinopathy
por: Gergely, Róbert, et al.
Publicado: (2020)

Mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy: systematic review and meta-analyses
por: Felipe, Camila Q., et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonist Treatment for Steroid-Induced Central Serous Chorioretinopathy Patients with Continuous Systemic Steroid Treatment
por: Kim, Jin Young, et al.
Publicado: (2018)

Comparison of microbiology and visual outcomes of patients undergoing small-gauge and 20-gauge vitrectomy for endophthalmitis
por: Almeida, David RP, et al.
Publicado: (2016)

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy
por: Daruich, Alejandra, et al.
Publicado: (2016)

Long-term outcomes in patients undergoing vitrectomy for retinal detachment due to viral retinitis
por: Almeida, David RP, et al.
Publicado: (2015)

Attaining functional levels of visual acuity after vitrectomy for retinal detachment secondary to proliferative diabetic retinopathy
por: Ricca, Aaron, et al.
Publicado: (2020)

Brachytherapy for Central Serous Chorioretinopathy
por: Arora, Supriya, et al.
Publicado: (2022)

Photodynamic therapy combined with antivascular endothelial growth factor treatment for recalcitrant chronic central serous chorioretinopathy
por: Asahi, Masumi G, et al.
Publicado: (2017)

Central serous chorioretinopathy in primary hyperaldosteronism
por: van Dijk, Elon H. C., et al.
Publicado: (2016)

Treatment of central serous chorioretinopathy with topical NSAIDs
por: Bahadorani, Sepehr, et al.
Publicado: (2019)

The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes
por: Giannopoulos, Konstantinos, et al.
Publicado: (2021)

Traumatic central serous chorioretinopathy
por: Ramchandani, Suresh, et al.
Publicado: (2015)

Traumatic central serous chorioretinopathy
por: Steeples, Laura, et al.
Publicado: (2015)

Atypical Central Serous Chorioretinopathy
por: Cebeci, Zafer, et al.
Publicado: (2017)

Biomarkers for central serous chorioretinopathy
por: Nkrumah, Gideon, et al.
Publicado: (2020)

Central Serous Chorioretinopathy Classification
por: Vilela, Manuel, et al.
Publicado: (2020)

Central serous chorioretinopathy in pregnancy
por: Ochinciuc, Radu, et al.
Publicado: (2022)

Central serous chorioretinopathy: Treatment
por: Park, Jong Beom, et al.
Publicado: (2022)

Management of chronic central serous chorioretinopathy
por: Hanumunthadu, Daren, et al.
Publicado: (2018)

Why are mineralocorticoid receptor antagonists cardioprotective?
por: Chai, Wenxia, et al.
Publicado: (2006)

Systemic complement activation in central serous chorioretinopathy
por: van Dijk, Elon H. C., et al.
Publicado: (2017)

Central Serous Chorioretinopathy: Multimodal Imaging and Management Options
por: Iyer, Prashanth G., et al.
Publicado: (2020)

Central Serous Chorioretinopathy Analyzed by Multimodal Imaging
por: Han, Liang, et al.
Publicado: (2021)

Characteristics of Central Serous Chorioretinopathy without Leakage
por: Parameswarappa, Deepika C., et al.
Publicado: (2021)

Central serous chorioretinopathy in active endogenous Cushing’s syndrome
por: Brinks, Joost, et al.
Publicado: (2021)

Central serous chorioretinopathy secondary to trauma
por: Jackson, Thomas E., et al.
Publicado: (2012)

Central Serous Chorioretinopathy after Rhinoplasty
por: Moschos, Marilita M., et al.
Publicado: (2010)

Photodynamic Therapy and Central Serous Chorioretinopathy
por: Siaudvytyte, Lina, et al.
Publicado: (2012)

Comment on: Traumatic central serous chorioretinopathy
por: Agarwal, Manisha, et al.
Publicado: (2015)

Advances in the treatment of central serous chorioretinopathy
por: Abouammoh, Marwan A.
Publicado: (2015)

Comment on: Traumatic central serous chorioretinopathy
por: Takkar, Brijesh, et al.
Publicado: (2016)

Operating room central serous chorioretinopathy
por: Mansour, Ahmad M, et al.
Publicado: (2017)

Central Serous Chorioretinopathy: Treatment with Laser
por: Battaglia Parodi, Maurizio, et al.
Publicado: (2020)

Central Serous Chorioretinopathy: Pathogenesis and Management
por: Semeraro, Francesco, et al.
Publicado: (2019)

Anxiolytics in the treatment of central serous chorioretinopathy
por: Dudani, Ajay I, et al.
Publicado: (2021)

Anxiolytics in the treatment of central serous chorioretinopathy
por: Dudani, Ajay I, et al.
Publicado: (2022)

CILIOCHOROIDAL EFFUSION IN CENTRAL SEROUS CHORIORETINOPATHY
por: Terao, Nobuhiro, et al.
Publicado: (2022)

Central Serous Chorioretinopathy Associated with Tadalafil
por: Alsarhani, Abdulaziz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_88fhrltkples8rcptrsm6fusnh